Company news
EchoIQ Limited news in 2022
EchoIQ Limited's news releases, calls and decks from 2022, newest first.
Positive Interim Results From Clinical Trial at St Vincents
December 14, 2022
Echo IQ Launches EchoSolv for Immediate Distribution
December 6, 2022
Echo IQ Announces Positive Results From US Clinical Study
November 30, 2022
Amendment to Appendix 4C
November 11, 2022
Quarterly Activities/Appendix 4C Cash Flow Report - Sept
October 28, 2022
Reinstatement to Official Quotation
October 12, 2022
Echo IQ Selected for HeartX Accelerator & Funding
October 11, 2022
Suspension from Official Quotation
October 6, 2022
New Research Presented at Leading Cardiology Conference
August 30, 2022
New Clinical Study with World-Leading US Teaching Hospital
July 26, 2022
Updated Appendix 4C Quarterly Cash Flow Report
July 19, 2022
Quarterly Activities/Appendix 4C Cash Flow Report - June
July 18, 2022
Presentation of Research Findings Behind Echo IQ Algorithm
July 6, 2022
Sale of Prometheus Information Pty. Limited
May 8, 2022
Formation of Scientific Advisory Board
April 25, 2022
Quarterly Activities/Appendix 4C Cash Flow Report - March
April 12, 2022
Echo IQ: Application for quotation of securities - EIQ
April 4, 2022
Echo IQ: Notification regarding unquoted securities - EIQ
March 21, 2022
Appendix 4D 31 December 2021
February 28, 2022
Decks in 2022
- Investor Presentation (April 2022)
Investor deck · 17 slides · Apr 28, 2022
- Investor Presentation (February 2022)
Investor deck · 20 slides · Feb 4, 2022